A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes Mellitus

Interleukin I (lL-I) is selectively cytotoxic to the insulin producing beta cell of pancreatic islets. This effect may be due to IL-I induced generation of reactive oxygen species and nitric oxide. Since beta cells contain low amounts of the superoxide radical scavenger enzyme manganese superoxide d...

Full description

Bibliographic Details
Main Authors: Flemming Pociot, Tove Lorenzen, JøRn Nerup
Format: Article
Language:English
Published: Hindawi Limited 1993-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/1993/678310
id doaj-ec8c73a4ce6d48daa6c2feac076cb664
record_format Article
spelling doaj-ec8c73a4ce6d48daa6c2feac076cb6642020-11-24T20:43:09ZengHindawi LimitedDisease Markers0278-02401875-86301993-01-01115-626727410.1155/1993/678310A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes MellitusFlemming Pociot0Tove Lorenzen1JøRn Nerup2Stena Diabetes Center, DK-2820 Gentalte, DenmarkStena Diabetes Center, DK-2820 Gentalte, DenmarkStena Diabetes Center, DK-2820 Gentalte, DenmarkInterleukin I (lL-I) is selectively cytotoxic to the insulin producing beta cell of pancreatic islets. This effect may be due to IL-I induced generation of reactive oxygen species and nitric oxide. Since beta cells contain low amounts of the superoxide radical scavenger enzyme manganese superoxide dismutase (MnSOD), this may leave beta cells more susceptible to IL-I than other cell types. Genetic variation in the MnSOD locus could reflect differences in scavenger potential. We, therefore, studied possible restriction fragment length polymorphisms (RFLPs) of this locus in patients with insulin-dependent diabetes mellitus (100M) (n= 154) and control individuals (n=178), Taql revealed a double diallelic RFLP in patients as well as in controls. No overall difference in allelic or genotype frequencies were observed between 100M patients and control individuals (p=0.11) and no significant association of any particular RFLP pattern with 100M was found. Structurally polymorphic MnSOD protein variants with altered activities have been reported. If genetic variation results in MnSOD variants with reduced activities, the MnSOD locus may still be a candidate gene for 100M susceptibility. Whether the RFLPs reported in this study reflects differences in gene expression level, protein level and/or specific activity of the protein is yet to be studied.http://dx.doi.org/10.1155/1993/678310
collection DOAJ
language English
format Article
sources DOAJ
author Flemming Pociot
Tove Lorenzen
JøRn Nerup
spellingShingle Flemming Pociot
Tove Lorenzen
JøRn Nerup
A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes Mellitus
Disease Markers
author_facet Flemming Pociot
Tove Lorenzen
JøRn Nerup
author_sort Flemming Pociot
title A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes Mellitus
title_short A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes Mellitus
title_full A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes Mellitus
title_fullStr A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes Mellitus
title_full_unstemmed A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin-Dependent Diabetes Mellitus
title_sort manganese superoxide dismutase (sod2) gene polymorphism in insulin-dependent diabetes mellitus
publisher Hindawi Limited
series Disease Markers
issn 0278-0240
1875-8630
publishDate 1993-01-01
description Interleukin I (lL-I) is selectively cytotoxic to the insulin producing beta cell of pancreatic islets. This effect may be due to IL-I induced generation of reactive oxygen species and nitric oxide. Since beta cells contain low amounts of the superoxide radical scavenger enzyme manganese superoxide dismutase (MnSOD), this may leave beta cells more susceptible to IL-I than other cell types. Genetic variation in the MnSOD locus could reflect differences in scavenger potential. We, therefore, studied possible restriction fragment length polymorphisms (RFLPs) of this locus in patients with insulin-dependent diabetes mellitus (100M) (n= 154) and control individuals (n=178), Taql revealed a double diallelic RFLP in patients as well as in controls. No overall difference in allelic or genotype frequencies were observed between 100M patients and control individuals (p=0.11) and no significant association of any particular RFLP pattern with 100M was found. Structurally polymorphic MnSOD protein variants with altered activities have been reported. If genetic variation results in MnSOD variants with reduced activities, the MnSOD locus may still be a candidate gene for 100M susceptibility. Whether the RFLPs reported in this study reflects differences in gene expression level, protein level and/or specific activity of the protein is yet to be studied.
url http://dx.doi.org/10.1155/1993/678310
work_keys_str_mv AT flemmingpociot amanganesesuperoxidedismutasesod2genepolymorphismininsulindependentdiabetesmellitus
AT tovelorenzen amanganesesuperoxidedismutasesod2genepolymorphismininsulindependentdiabetesmellitus
AT jørnnerup amanganesesuperoxidedismutasesod2genepolymorphismininsulindependentdiabetesmellitus
AT flemmingpociot manganesesuperoxidedismutasesod2genepolymorphismininsulindependentdiabetesmellitus
AT tovelorenzen manganesesuperoxidedismutasesod2genepolymorphismininsulindependentdiabetesmellitus
AT jørnnerup manganesesuperoxidedismutasesod2genepolymorphismininsulindependentdiabetesmellitus
_version_ 1716820389092392960